The curious case of clioquinol

Nature Medicine

Volumn 15, Issue 4, 2009, Pages 356-359

  Cahoon, Lauren ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; ANTIAMEBIC AGENT; CLIOQUINOL; COPPER; IRON; PBT2; PLACEBO; UNCLASSIFIED DRUG; ZINC;

ALZHEIMER DISEASE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLINDNESS; CANCER INHIBITION; CHELATION; CLINICAL TRIAL; DEGENERATIVE DISEASE; DIARRHEA; DOSE TIME EFFECT RELATION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; GASTROINTESTINAL SYMPTOM; HUMAN; INDIGESTION; NONHUMAN; OUTCOME ASSESSMENT; PAIN; PARALYSIS; PARESTHESIA; PLAQUE FORMING CELL; PRIORITY JOURNAL; SUBACUTE MYELOOPTIC NEUROPATHY; TREATMENT OUTCOME;

ALZHEIMER DISEASE; ANTI-INFECTIVE AGENTS, LOCAL; BLINDNESS; CLIOQUINOL; HUMANS; JAPAN; MEMORY; MEMORY DISORDERS; NEURODEGENERATIVE DISEASES; PARALYSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 64149090846     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0409-356     Document Type: Article

References (10)

1. Schaumburg, H. Experimental and Clinical Neurotoxicology (ed. Spencer, P.) Ch. 27, 395-406 (Oxford University Press, New York, 2000).
2. Cherny, R.A. et al. Neuron 30, 665-676 (2001).
3. Ritchie, C.W. Arch. Neurol. 60, 1685-1691 (2003).
4. Nakae, K., Yamamoto, S., Shigematsu, I. & Kono R. Lancet 301, 171-173 (1973).
5. Shigematsu, I., Yanagawa, H., Yamamoto, S. & Nakae, K. Jpn. J. Med. Sci. Biol. 28, 23-33 (1975).
6. Lannfelt, L. et al. Lancet Neurol. 7, 779-786 (2008).
7. Nguyen, T., Hamby, A. & Massa, S.M. Proc. Natl. Acad. Sci. 102, 11840-11845 (2005).
8. Kaur, D. et al. Neuron 37, 899-909 (2003).
9. Wang, Y. et al. J. Biol. Chem. 284, 314-323 (2009).
10. Ding, W.Q. et al. Cancer Res. 65, 3389-3395 (2005).